76 research outputs found
SN 2010U: A Luminous Nova in NGC 4214
The luminosity, light curve, post-maximum spectrum, and lack of a progenitor on deep pre-outburst images suggest that SN 2010U was a luminous, fast nova. Its outburst magnitude is consistent with that for a fast nova using the maximum magnitude-rate of decline relationship for classical novae
Discovery of a Gas-Rich Companion to the Extremely Metal-Poor Galaxy DDO 68
We present HI spectral-line imaging of the extremely metal-poor galaxy DDO
68. This system has a nebular oxygen abundance of only 3% Z, making
it one of the most metal-deficient galaxies known in the local volume.
Surprisingly, DDO 68 is a relatively massive and luminous galaxy for its metal
content, making it a significant outlier in the mass-metallicity and
luminosity-metallicity relationships. The origin of such a low oxygen abundance
in DDO 68 presents a challenge for models of the chemical evolution of
galaxies. One possible solution to this problem is the infall of pristine
neutral gas, potentially initiated during a gravitational interaction. Using
archival HI spectral-line imaging obtained with the Karl G. Jansky Very Large
Array, we have discovered a previously unknown companion of DDO 68. This
low-mass (M 2.810 M), recently
star-forming (SFR 1.410 M yr,
SFR 710 M yr) companion has
the same systemic velocity as DDO 68 (V 506 km s; D
12.740.27 Mpc) and is located at a projected distance of 42 kpc. New HI
maps obtained with the 100m Robert C. Byrd Green Bank Telescope provide
evidence that DDO 68 and this companion are gravitationally interacting at the
present time. Low surface brightness HI gas forms a bridge between these
objects.Comment: Accepted for publication in the Astrophysical Journal Letter
The Panchromatic Hubble Andromeda Treasury I: Bright UV Stars in the Bulge of M31
As part of the Panchromatic Hubble Andromeda Treasury (PHAT) multi-cycle
program, we observed a 12' \times 6.5' area of the bulge of M31 with the
WFC3/UVIS filters F275W and F336W. From these data we have assembled a sample
of \sim4000 UV-bright, old stars, vastly larger than previously available. We
use updated Padova stellar evolutionary tracks to classify these hot stars into
three classes: Post-AGB stars (P-AGB), Post-Early AGB (PE-AGB) stars and
AGB-manqu\'e stars. P-AGB stars are the end result of the asymptotic giant
branch (AGB) phase and are expected in a wide range of stellar populations,
whereas PE-AGB and AGB-manqu\'e (together referred to as the hot
post-horizontal branch; HP-HB) stars are the result of insufficient envelope
masses to allow a full AGB phase, and are expected to be particularly prominent
at high helium or {\alpha} abundances when the mass loss on the RGB is high.
Our data support previous claims that most UV-bright sources in the bulge are
likely hot (extreme) horizontal branch stars (EHB) and their progeny. We
construct the first radial profiles of these stellar populations, and show that
they are highly centrally concentrated, even more so than the integrated UV or
optical light. However, we find that this UV-bright population does not
dominate the total UV luminosity at any radius, as we are detecting only the
progeny of the EHB stars that are the likely source of the UVX. We calculate
that only a few percent of MS stars in the central bulge can have gone through
the HP-HB phase and that this percentage decreases strongly with distance from
the center. We also find that the surface density of hot UV-bright stars has
the same radial variation as that of low-mass X-ray binaries. We discuss age,
metallicity, and abundance variations as possible explanations for the observed
radial variation in the UV-bright population.Comment: Accepted for publication in Ap
The ACS Nearby Galaxy Survey Treasury IX. Constraining asymptotic giant branch evolution with old metal-poor galaxies
In an attempt to constrain evolutionary models of the asymptotic giant branch
(AGB) phase at the limit of low masses and low metallicities, we have examined
the luminosity functions and number ratio between AGB and red giant branch
(RGB) stars from a sample of resolved galaxies from the ACS Nearby Galaxy
Survey Treasury (ANGST). This database provides HST optical photometry together
with maps of completeness, photometric errors, and star formation histories for
dozens of galaxies within 4 Mpc. We select 12 galaxies characterized by
predominantly metal-poor populations as indicated by a very steep and blue RGB,
and which do not present any indication of recent star formation in their
color--magnitude diagrams. Thousands of AGB stars brighter than the tip of the
RGB (TRGB) are present in the sample (between 60 and 400 per galaxy), hence the
Poisson noise has little impact in our measurements of the AGB/RGB ratio. We
model the photometric data with a few sets of thermally pulsing AGB (TP-AGB)
evolutionary models with different prescriptions for the mass loss. This
technique allows us to set stringent constraints to the TP-AGB models of
low-mass metal-poor stars (with M<1.5 Msun, [Fe/H]<~-1.0). Indeed, those which
satisfactorily reproduce the observed AGB/RGB ratios have TP-AGB lifetimes
between 1.2 and 1.8 Myr, and finish their nuclear burning lives with masses
between 0.51 and 0.55 Msun. This is also in good agreement with recent
observations of white dwarf masses in the M4 old globular cluster. These
constraints can be added to those already derived from Magellanic Cloud star
clusters as important mileposts in the arduous process of calibrating AGB
evolutionary models.Comment: To appear in ApJ, a version with better resolution is in
http://stev.oapd.inaf.it/~lgirardi/rgbagb.pd
Ultrasound-facilitated, catheter-directed thrombolysis vs anticoagulation alone for acute intermediate-high-risk pulmonary embolism: Rationale and design of the HI-PEITHO study
BACKGROUND: Due to the bleeding risk of full-dose systemic thrombolysis and the lack of major trials focusing on the clinical benefits of catheter-directed treatment, heparin antiocoagulation remains the standard of care for patients with intermediate-high-risk pulmonary embolism (PE).
METHODS AND RESULTS: The Higher-Risk Pulmonary Embolism Thrombolysis (HI-PEITHO) study (ClinicalTrials.gov Identifier: NCT04790370) is a multinational multicenter randomized controlled parallel-group comparison trial. Patients with: (1) confirmed acute PE; (2) evidence of right ventricular (RV) dysfunction on imaging; (3) a positive cardiac troponin test; and (4) clinical criteria indicating an elevated risk of early death or imminent hemodynamic collapse, will be randomized 1:1 to treatment with a standardized protocol of ultrasound-facilitated catheter-directed thrombolysis plus anticoagulation, vs anticoagulation alone. The primary outcome is a composite of PE-related mortality, cardiorespiratory decompensation or collapse, or non-fatal symptomatic and objectively confirmed PE recurrence, within 7 days of randomization. Further assessments cover, apart from bleeding complications, a broad spectrum of functional and patient-reported outcomes including quality of life indicators, functional status and the utilization of health care resources over a 12-month follow-up period. The trial plans to include 406 patients, but the adaptive design permits a sample size increase depending on the results of the predefined interim analysis. As of May 11, 2022, 27 subjects have been enrolled. The trial is funded by Boston Scientific Corporation and through collaborative research agreements with University of Mainz and The PERT Consortium.
CONCLUSIONS: Regardless of the outcome, HI-PEITHO will establish the first-line treatment in intermediate-high risk PE patients with imminent hemodynamic collapse. The trial is expected to inform international guidelines and set the standard for evaluation of catheter-directed reperfusion options in the future
Evolution of Thermally Pulsing Asymptotic Giant Branch Stars V: Constraining the Mass Loss and Lifetimes of Intermediate Mass, Low Metallicity AGB Stars
Thermally pulsing asymptotic giant branch (TP-AGB) stars are relatively short lived (less than a few Myr), yet their cool effective temperatures, high luminosities, efficient mass loss, and dust production can dramatically affect the chemical enrichment histories and the spectral energy distributions of their host galaxies. The ability to accurately model TP-AGB stars is critical to the interpretation of the integrated light of distant galaxies, especially in redder wavelengths. We continue previous efforts to constrain the evolution and lifetimes of TP-AGB stars by modeling their underlying stellar populations. Using Hubble Space Telescope (HST) optical and near-infrared photometry taken of 12 fields of 10 nearby galaxies imaged via the Advanced Camera for Surveys Nearby Galaxy Survey Treasury and the near-infrared HST/SNAP follow-up campaign, we compare the model and observed TP-AGB luminosity functions as well as the ratio of TP-AGB to red giant branch stars. We confirm the best-fitting mass-loss prescription, introduced by Rosenfield et al., in which two different wind regimes are active during the TP-AGB, significantly improves models of many galaxies that show evidence of recent star formation. This study extends previous efforts to constrain TP-AGB lifetimes to metallicities ranging -1.59 less than or similar to [Fe/H] <= -0.56 and initial TP-AGB masses up to similar to 4 M-circle dot, which include TP-AGB stars that undergo hot-bottom burning. \ua9 2016. The American Astronomical Society. All rights reserved
Diagnosis, Treatment and Follow Up of Acute Pulmonary Embolism: Consensus Practice from the PERT Consortium
Pulmonary embolism (PE) is a life-threatening condition and a leading cause of morbidity and mortality. There have been many advances in the field of PE in the last few years, requiring a careful assessment of their impact on patient care. However, variations in recommendations by different clinical guidelines, as well as lack of robust clinical trials, make clinical decisions challenging. The Pulmonary Embolism Response Team Consortium is an international association created to advance the diagnosis, treatment, and outcomes of patients with PE. In this consensus practice document, we provide a comprehensive review of the diagnosis, treatment, and follow-up of acute PE, including both clinical data and consensus opinion to provide guidance for clinicians caring for these patients
- âŠ